As Precision Medicine has changed over the past several years, we have been diligent in ensuring that the composition of our Editorial Advisory Board reflects those changes. Our EAB represents how precision medicine has come to expand beyond cancer and sequencing to embrace other therapeutic areas and analytical domains. In addition to these areas, we also saw the need to draw from various organizations and institutions – therapeutic to diagnostic to analytical to academic. In light of these changes, the EAB now encompasses the range of scientific, technical, and medical disciplines in precision medicine. Experts have been added to keep pace with emerging capabilities, such as machine learning, artificial intelligence, and advanced computational methods. We look to our EAB for deep advice on topics and directions, using their input to shape content for you, the audience of the Journal and the Summits.
And, of course, we express our profound gratitude to them for their contribution and look to them for their ongoing support. Thank you!